U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06888128) titled 'State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma' on Feb. 21.
Brief Summary: The principal investigator for this study plans to build upon the psilocybin-assisted therapy intervention used in prior completed trials to conduct an open-label trial of two psilocybin administration sessions combined with psychotherapy to investigate the safety, tolerability, and clinical efficacy of psilocybin-assisted therapy for the treatment of PTSD in US Veterans.
Study Start Date: Jan. 30
Study Type: INTERVENTIONAL
Condition:
PTSD
Intervention:
DRUG: Psilocybin 15mg
Each participant will hav...